These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1905134)
1. An approach to the functional analysis of lecithin-cholesterol acyltransferase. Activation by recombinant normal and mutagenized apolipoprotein AI. Bruhn H; Stoffel W Biol Chem Hoppe Seyler; 1991 Mar; 372(3):225-34. PubMed ID: 1905134 [TBL] [Abstract][Full Text] [Related]
2. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation. Emmanuel F; Steinmetz A; Rosseneu M; Brasseur R; Gosselet N; Attenot F; Cuiné S; Séguret S; Latta M; Fruchart JC J Biol Chem; 1994 Nov; 269(47):29883-90. PubMed ID: 7961983 [TBL] [Abstract][Full Text] [Related]
3. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I. Chen CH; Albers JJ Eur J Biochem; 1986 Mar; 155(3):589-94. PubMed ID: 3082628 [TBL] [Abstract][Full Text] [Related]
5. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480 [TBL] [Abstract][Full Text] [Related]
6. [Over-expression in Escherichia coli and characterization of apolipoprotein AI]. Ding MS; Ma WF; Zhang MF; Liu DT; Guo MJ; Zhuang YP; Chu J; Zhang SL; Gong BQ Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):198-203. PubMed ID: 16013475 [TBL] [Abstract][Full Text] [Related]
7. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism. Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein AIV of human interstitial fluid is associated with apolipoprotein AI-containing but not with AII-containing particles. Ghalim N; Adlouni A; Saile R; Parra HJ; Benslimane A; Bard JM; Fruchart JC Int J Clin Lab Res; 1996; 26(4):224-8. PubMed ID: 9007611 [TBL] [Abstract][Full Text] [Related]
9. Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i. Subbaiah PV; Chen CH; Albers JJ; Bagdade JD Atherosclerosis; 1982 Nov; 45(2):181-90. PubMed ID: 7159494 [TBL] [Abstract][Full Text] [Related]
10. Variations in the apolipoprotein AI-CIII-AIV gene region and in lecithin:cholesterol acyltransferase concentration are determinants of plasma cholesterol concentrations. Kessling AM; Nanjee MN; Miller NE; Humphries SE Atherosclerosis; 1988 Mar; 70(1-2):13-9. PubMed ID: 2895659 [TBL] [Abstract][Full Text] [Related]
12. Lecithin cholesterol acyltransferase (LCAT) activity in the presence of Apo-AI-derived peptides exposed to disorder-order conformational transitions. Aguilar-Espinosa SL; Mendoza-Espinosa P; Delgado-Coello B; Mas-Oliva J Biochem Biophys Res Commun; 2013 Nov; 441(2):469-75. PubMed ID: 24383078 [TBL] [Abstract][Full Text] [Related]
13. Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144. Teh EM; Chisholm JW; Dolphin PJ; Pouliquen Y; Savoldelli M; de Gennes JL; Benlian P Atherosclerosis; 1999 Sep; 146(1):141-51. PubMed ID: 10487497 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli. Pyle LE; Sawyer WH; Fujiwara Y; Mitchell A; Fidge NH Biochemistry; 1996 Sep; 35(37):12046-52. PubMed ID: 8810909 [TBL] [Abstract][Full Text] [Related]
15. Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins. Elkhalil L; Majd Z; Bakir R; Perez-Mendez O; Castro G; Poulain P; Lacroix B; Duhal N; Fruchart JC; Luc G Metabolism; 1997 May; 46(5):474-83. PubMed ID: 9160810 [TBL] [Abstract][Full Text] [Related]
16. Influence of serum amyloid A on cholesterol esterification in human plasma. Steinmetz A; Hocke G; Saïle R; Puchois P; Fruchart JC Biochim Biophys Acta; 1989 Nov; 1006(2):173-8. PubMed ID: 2512983 [TBL] [Abstract][Full Text] [Related]
19. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Jeenah M; Kessling A; Miller N; Humphries S Mol Biol Med; 1990 Jun; 7(3):233-41. PubMed ID: 1977072 [TBL] [Abstract][Full Text] [Related]
20. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation. Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]